CFC Planning Co LLC

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1854428 CICERO, IN

Position in PTGX

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$205,321

New position

Shares Held

1,675

first reported quarter

Ownership

0.003%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#262

of 341 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CFC Planning Co LLC holds $2,133,820 across 3 Biotechnology names. PTGX ranks #2 (9.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	9,218	$1,726,347
2	PTGX	Protagonist Therapeutics, Inc This page	1,675	$205,321
3	SYRE	Spyre Therapeutics, Inc.	2,277	$202,152

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$205,321	1,675	—	Shares	Sole	2026-08-05
No filing history on record for this holder in this stock.